MMR vaccine

No summary available for this substance.

MMR vaccine

The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.

Category
Vaccine
Molecular Formula
Not applicable
Mechanism of Action
The MMR vaccine works by stimulating the immune system to produce antibodies against measles, mumps, and rubella, without causing the diseases. This prepares the body to fight the viruses if they are encountered again, preventing or significantly reducing the severity of the diseases.
Evidence Grade
A (Strong scientific evidence for use and effectiveness)

Other Names

  • Measles, Mumps, and Rubella Vaccine
  • MMR-II
  • Priorix

Primary Benefits

  • Prevents measles
  • Prevents mumps
  • Prevents rubella

Recommended Dosage

Children 2 doses
Adults 1 or 2 doses depending on indication

Side Effects

  • Fever
  • Mild rash
  • Swelling of glands in the cheeks or neck

Precautions

  • Pregnancy
  • Severe immunodeficiency
  • Severe allergic reactions to previous dose or vaccine component

Interactions

  • Immunosuppressive therapy
  • Certain antiviral drugs

Key References

  • CDC guidelines for MMR vaccination
  • WHO position paper on Measles vaccines
Longevity Supplements, Predatory Experts & Continuous Glucose Monitors | Dr. Eric Topol
Exploring Aging, Genetics, Disease Prevention, Nutrition, and Lifestyle Factors 1:01:15 0
“The MMR vaccine has immunity waning at 4.5%. Which is just completely wrong. Lancet uh published the results and it's 4% not 4.5.”

No comments yet.

View all comments (0)